CYP3A4 and Anxiety: Patients receiving NMVr should undergo neuropsychiatric monitoring, particularly those with preexisting psychiatric conditions, as ritonavir can disrupt neurotransmitter metabolism via CYP3A4 inhibition, exacerbating anxiety and sleep disturbances [39].